NIH-funded research R01 grant

DNMT3A as a Target to Protect Hip Joints in Osteoarthritis

Official title: DNMT3A as an Epigenetic Transcriptional Therapeutic Target in the Progression of Hip Osteoarthritis

Funded at Washington University · NIH-11346619 · Data updated 2026-11-12

A patient-friendly study aims to see if turning down a specific gene pathway can slow cartilage damage in people with femoroacetabular impingement and early hip OA.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 5, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$676,210
NIH project number1R01AR087597-01
Project IDNIH-11346619 on NIH RePORTER

Who could benefit from this research

Could help

Adults with FAI or early hip OA who are undergoing or have access to cartilage tissue samples for research.

Less likely to help

Patients without FAI or OA or without access to relevant cartilage samples may not benefit from this specific study.

What this research studies

This project looks at how a gene called DNMT3A influences cartilage breakdown in the hip. Researchers will test whether using a tiny genetic silencing tool (siRNA) can boost a protective gene (PPARγ) and reduce inflammation-driven damage in cartilage cells from healthy donors and patients with FAI or OA. The work involves lab experiments on human cartilage cells to see how the DNMT3A pathway affects cartilage health. If successful, this could point toward a new approach to delay or prevent OA progression in affected individuals.

Why it matters

Potential benefit: If the approach works, it could lead to new therapies that protect hip cartilage and slow OA progression.

How similar studies have gone: Previous work suggests DNMT3A and PPARγ interactions influence cartilage health, with potential for translational therapies.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Pascual-Garrido, Cecilia — Washington University
  • Study coordinator: Pascual-Garrido, Cecilia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.